Completed PHASE2 INTERVENTIONAL 1-arm NCT05019651

Acceptability and Feasibility of Apollo in Veterans With a History of PTSD (Apollo PTSD)

Acceptability and Feasibility of Apollo Wearable System, Tuned Vibroacoustic Stimulation (TVS) in Veterans With a History of Post-traumatic Stress Disorder (PTSD)

Sponsor: Apollo Neuroscience

Conditions PTSD

Interventions Apollo Wearable System

Updated 7 times since 2021 Last updated: Nov 13, 2025 Started: Feb 1, 2022 Primary completion: Jun 30, 2023 Completion: Jun 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates PTSD and is currently completed. Apollo Neuroscience leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Dec 2025 — Present [monthly]

Completed PHASE2
Nov 2025 — Dec 2025 [monthly]

Completed PHASE2
Sep 2024 — Nov 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Oct 2023 — Jul 2024 [monthly]

Completed PHASE2

Status: Recruiting → Completed

▶ Show 2 earlier versions

Jun 2022 — Oct 2023 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Jun 2022 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Apollo Neuroscience
Lisa Brenner

Data source: VA Eastern Colorado Health Care System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aurora, United States